Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 1, 2026.

Sepsis in the burn patient: a different problem than sepsis in the general population

David G. Greenhalgh

Burns & Trauma · 2017 · Review · CC BY-NC

doi:10.1186/s41038-017-0089-5

Abstract

Sepsis has recently been defined as “life-threatening organ dysfunction caused by a dysregulated host response to infection”. A great amount of effort has been made to develop early treatments for sepsis through the Surviving Sepsis Campaign. There are similar but slightly different recommendations for the treatment of sepsis in the pediatric population. These international efforts have led to earlier diagnosis and treatments for sepsis that have led to improvements in survival. Sepsis is also the leading cause of death in the burn patient but most clinical sepsis studies have excluded burns. The reason for the exclusion is that the sepsis found in burn patients is different than that of the general population. The early treatment strategies, such as those directed by the Surviving Sepsis Campaign, focus on patients presenting to hospitals with recent signs of infection. Burn patients lose their primary barrier to infection, the skin, and thus the risk of infection persists as long as that barrier is absent. Efforts have been made to define sepsis, septic shock and infection in the burn population but there is constant need for revisions. One focus of this review is to discuss the differences in burn sepsis versus sepsis of the general population. Children often have profound responses to sepsis but can also make remarkable recoveries. This review will also explore problems specific to pediatric burns. The treatment of burns requires a continuous vigilance to watch for the subtle early signs of sepsis and then expeditious initiation of aggressive therapy. Strategies covering optimal management of pediatric burn sepsis will also be summarized.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 50

  1. 1.

    Medzhitov R. Original physiological roles of inflammation. Nature. 2008;454:428-35.

    Not in our library10.1038/nature07201

  2. 2.

    Du Clos TW. C-reactive protein and the immune response. Sci Med. 2002;8:108-17.

    Not in our library

  3. 3.

    Komarova YA, Kruse K, Mehta D, Mali AB. Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res. 2017;120:179-206.

    Not in our library10.1161/circresaha.116.306534

  4. 4.

    Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nature Rev Immunol. 2007;7:803-15.

    Not in our library10.1038/nri2171

  5. 5.

    Housinger TA, Brinkerhoff C, Warden GD. The relationship between platelet count, sepsis, and survival in pediatric burn patients. Arch Surg. 1993;128:65-6.

    Not in our library10.1001/archsurg.1993.01420130073011

  6. 6.

    Marck RE, Montagne HL, Tuinebreijer WE, Breederveld RS. Time course of thrombocytes in burn patients and its predictive value for outcome. Burns. 2013;39:714-22.

    Not in our library10.1016/j.burns.2013.01.015

  7. 7.
  8. 8.

    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.

    Not in our library10.1378/chest.101.6.1644

  9. 9.

    McConnell KW, Coopersmith CM. Organ failure avoidance and mitigation strategies in surgery. Surg Clin N Am. 2012;92:307-19.

    Not in our library10.1016/j.suc.2012.01.001

  10. 10.

    Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: Genetic events and selective pressures. Nature Rev Genet. 2010;11:47-59.

    Not in our library10.1038/nrg2703

  11. 11.

    Litman GW, Rast JP, Fugmann SD. The origins of vertebrate adaptive immunity. Nature Rev Immunol. 2010;10:543-53.

    Not in our library10.1038/nri2807

  12. 12.

    Ebert G. Immunity by equilibrium. Nature Rev Immunol. 2016;16:524-32.

    Not in our library10.1038/nri.2016.75

  13. 13.

    Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125-8.

    Not in our library10.1097/00003246-199607000-00010

  14. 14.

    Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50.

    Not in our library10.1056/nejmra021333

  15. 15.

    Nast-Kolb DM, Aufmkolk M, Rucholt S, Obertacke U, Waydhas C. Multiple organ failure. Still a major cause of morbidity but not mortality in blunt multiple trauma. J Trauma. 2001;51:835-41.

    Not in our library10.1097/00005373-200111000-00003

  16. 16.

    Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36:691-709.

    Not in our library10.1016/j.injury.2004.12.037

  17. 17.

    Xiao W, Mindronos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581-90.

    Not in our library10.1084/jem.20111354

  18. 18.

    Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594-605.

    Not in our library10.1001/jama.2011.1829

  19. 19.

    Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature Rev Immunol. 2013;13:862-74.

    Not in our library10.1038/nri3552

  20. 20.

    Lamas D. Chronic critical illness. N Engl J Med. 2014;370:175-7.

    Not in our library10.1056/nejmms1310675

  21. 21.

    Kahn JM, Le T, Angus DC, Cox CE, Hough CL, White DB, et al. The epidemiology of chronic critical illness in the United States. Crit Care Med. 2015;43:282–7.

    Not in our library10.1097/ccm.0000000000000710

  22. 22.

    Manz MG, Boettcher S. Emergency granulopoiesis. Nature Rev Immunol. 2014;14:302-14.

    Not in our library10.1038/nri3660

  23. 23.

    Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med. 2005;201:1771-80.

    Not in our library10.1084/jem.20041419

  24. 24.

    Nagaraj S, Youn J-I, Gabrilovich DI. Reciprocal relationship between myeloid-derived suppressor cells and T cells. J Immunol. 2013;191:17-23.

    Not in our library10.4049/jimmunol.1300654

  25. 25.

    Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev Immunol. 2009;9:162-74.

    Not in our library10.1038/nri2506

  26. 26.

    Mira JC, Gentile LF, Mathias J, Efron PA, Brakenridge SC, Mohr AM, et al. Sepsis pathophysiology, chronic critical illness, and the persistent inflammatory-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45:253-62.

    Not in our library10.1097/ccm.0000000000002074

  27. 27.

    Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis guidelines for severe sepsis and septic shock. Crit Care Med. 2004;32:858-73.

    Not in our library10.1097/01.ccm.0000117317.18092.e4

  28. 28.

    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228.

    Not in our library10.1007/s00134-012-2769-8

  29. 29.

    Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749-55.

    Not in our library10.1097/ccm.0000000000000330

  30. 30.

    Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308-16.

    Not in our library10.1001/jama.2014.2637

  31. 31.

    Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017. Doi: 10.1056/NEJMoa1703058 [Epub ahead of print]

    Not in our library10.1056/nejmoa1703058

  32. 32.

    Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–10.

    Not in our library10.1001/jama.2016.0287

  33. 33.

    Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis for The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:762–74.

    Not in our library10.1001/jama.2016.0288

  34. 34.

    Shankar-Hari M, Phillips GS, Levy LM, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock for The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:775–87.

    Not in our library10.1001/jama.2016.0289

  35. 35.

    Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.

    Not in our library10.1007/bf01709751

  36. 36.

    Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486-552.

    Not in our library10.1097/ccm.0000000000002255

  37. 37.

    Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonzo-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.

    Not in our library10.1136/bmj.39489.470347.ad

  38. 38.

    Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Yttter Y, Schunemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336:995-8.

    Not in our library10.1136/bmj.39490.551019.be

  39. 39.

    Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ. 2008;336:1049-51.

    Not in our library10.1136/bmj.39493.646875.ae

  40. 40.

    Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lunginjury and acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.

    Not in our library10.1056/nejm200005043421801

  41. 41.

    Davis AL, Carcillo JA, Aneja RK, Deymann AG, Lin JC, Nguyen TC, et al. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med. 2017;45:1061-93.

    Not in our library10.1097/ccm.0000000000002425

  42. 42.

    Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003;112:793–9.

    Not in our library10.1542/peds.112.4.793

  43. 43.

    Ninis N, Phillips C, Bailey L, Pollock JI, Nadel S, Britto J, et al. The role of healthcare delivery in the outcome of meningococcal disease in children: Case-control study of fatal and non-fatal cases. BMJ. 2005;330:1475-82.

    Not in our library10.1136/bmj.330.7506.1475

  44. 44.

    Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodyamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32:1928-48.

    Not in our library10.1097/01.ccm.0000139761.05492.d6

  45. 45.

    Greenhalgh DG, Saffle JR, Holmes JH, Gamelli R, Palmieri TL, Horton JW, et al. American Burn Association Consensus Conference to define sepsis and infection in burns. J Burn Care Res. 2007;28:776-90.

    Not in our library10.1097/bcr.0b013e3181599bc9

  46. 46.

    Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;33:1538-48.

    Not in our library10.1097/01.ccm.0000168253.91200.83

  47. 47.

    Kraft R, Herndon DN, Finnerty CC, Shahrokhi S, Jeschke MG. Occurrence of multiorgan dysfunction in pediatric burn patients. Incidence and clinical outcome. Ann Surg. 2014;259:381-7.

    Not in our library10.1097/sla.0b013e31828c4d04

  48. 48.

    Upperman JS, Bucuvalas JC, Williams FN, Cairns BA, Cox Jr CS, Doctor A, et al. Specific etiologies associated with the multiple dysfunction syndrome in children: Part 2. Pediatr Crit Care Med. 2017;18:S58–66.

    Not in our library10.1097/pcc.0000000000001051

  49. 49.

    Mann-Salinas EA, Baun MM, Meininger JC, Murray CK, Aden JK, Wolf SE, et al. Novel predictors of sepsis outperform the American Burn Association sepsis criteria in the burn intensive care unit patient. J Burn Care Res. 2013;34:31–43.

    Not in our library10.1097/bcr.0b013e31826450b5

  50. 50.

    Rech MA, Mosier MJ, Zelisko S, Netzer G, Kovacs EJ, Afshar M. Comparison of automated methods versus the American Burn Association sepsis definition to identify sepsis and sepsis with organ dysfunction/septic shock in burn-injured adults. J Burn Care Res. 2017.

    Not in our library10.1097/bcr.0000000000000504

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.